Health and Wellness Coaching to Improve Adherence to Healthy Habits and Treatment Plans in Papillary and Follicular Thyroid Cancer Survivors
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Counseling, Interview, Questionnaire Administration.
- Who it may be relevant to
- Registry conditions: Thyroid Gland Follicular Carcinoma, Thyroid Gland Papillary Carcinoma. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Health and Wellness Coaching to Improve Patient Activation and Adherence to Healthy Habits in Differentiated Thyroid Cancer Care: A Mixed-Methods Pilot Study
Overview
This clinical trial evaluates the impact of a patient-centered health and wellness coaching (HWC) intervention on adherence to treatment plans and healthy lifestyle practices in patients with papillary or follicular thyroid cancer. Treatment for thyroid cancer often involves surgery, radioactive iodine and/or lifelong levothyroxine with regular monitoring of thyroid stimulating hormone levels. Despite strong survival rates, patients frequently report fatigue, cognitive issues, mood changes, and disruptions in daily life. Treatment burden and psychosocial strain often impair the ability to follow the treatment plan and healthy lifestyle. Studies have shown that HWC motivates patients to take ownership and accountability to perform positive and healthy behavioral changes. HWC may have a positive impact on health-related goal-setting processes and improve self-care and healthcare outcomes in certain settings. It is not yet known how HWC impacts thyroid cancer patients. Incorporating HWC into survivorship care may improve adherence to treatment plans and healthy lifestyle practices in patients with papillary or follicular thyroid cancer.
Interventions
- Other Counseling
Attend HWC sessions - Other Interview
Ancillary studies - Other Questionnaire Administration
Ancillary studies
Primary outcome measures
- Recruitment rate [Time frame: Up to 1 year]
- Retention rate [Time frame: At 6 months]
- Session completion rates [Time frame: Up to 6 months]
- Study completion rate [Time frame: At baseline and at 6 months]
- Intervention fidelity [Time frame: Up to 6 months]
Secondary outcome measures (3)
- Rate of adherence to medication schedule [Time frame: Up to 6 months]
- Self-reported rate of adherence to lifestyle care plan [Time frame: Up to 6 months]
- Change in LMWPHI score [Time frame: At baseline and at 6 months]
Eligibility criteria
Inclusion criteria
- Adults ≥ 18 years
- Histologically confirmed papillary or follicular thyroid carcinoma
- Status post total thyroidectomy ± radioactive iodine therapy
- Receiving levothyroxine monotherapy (no triiodothyronine \[T3\] or desiccated thyroid products)
- Thyroid-stimulating hormone (TSH) < 4 uIU/mL at ≥ 3 months post-thyroidectomy
- English proficiency
- Ability to provide informed consent
Exclusion criteria
- Medullary or anaplastic thyroid carcinoma
- Current systemic therapy for thyroid or other cancers
- Cognitive or psychiatric impairment precluding participation
- Inability to complete study procedures
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Supportive care
Study locations
United States · 1 center
- Mayo Clinic in Florida — Jacksonville
Identifiers
NCT: NCT07545837 · 25-011068 · BeWell360